Literature DB >> 15947217

Predictors of schizophrenia--a review.

Pirjo Mäki1, Juha Veijola, Peter B Jones, Graham K Murray, Hannu Koponen, Pekka Tienari, Jouko Miettunen, Päivikki Tanskanen, Karl-Erik Wahlberg, Johanna Koskinen, Erika Lauronen, Matti Isohanni.   

Abstract

Schizophrenia is an aetiologically heterogeneous syndrome that usually becomes overtly manifest in adolescence and early adulthood, but in many cases subtle impairments in neurointegrative function are present from birth; hence it is considered to be a disorder with a neurodevelopmental component. The strongest risk factor that has been identified is familial risk with genetic loading. Other risk factors include pregnancy and delivery complications, infections during pregnancy, disturbances of early neuromotor and cognitive development and heavy cannabis use in adolescence. Unfortunately, to date it has not been possible to utilize the predictors of the disorder that have been identified in primary preventative interventions in a general population. However, some authors have claimed that in future it might be possible to reduce the risk for developing schizophrenia through general health policy. In clinical settings, it is helpful to map out possible early risk factors, at least familial risk for psychosis, especially in child, adolescent and young adult mental patients. Furthermore, in the future we may have predictive models combining data from genetic factors for schizophrenia, antenatal risk factors, childhood and adolescent development and clinical symptomatology, as well as brain structural and functional abnormalities.

Entities:  

Mesh:

Year:  2005        PMID: 15947217     DOI: 10.1093/bmb/ldh046

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  36 in total

1.  Premorbid multivariate markers of neurodevelopmental instability in the prediction of adult schizophrenia-spectrum disorder: a high-risk prospective investigation.

Authors:  Shana Golembo-Smith; Jason Schiffman; Emily Kline; Holger J Sørensen; Erik L Mortensen; Laura Stapleton; Kentaro Hayashi; Niels M Michelsen; Morten Ekstrøm; Sarnoff Mednick
Journal:  Schizophr Res       Date:  2012-06-02       Impact factor: 4.939

Review 2.  The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development.

Authors:  Regina Sullivan; Donald A Wilson; Joram Feldon; Benjamin K Yee; Urs Meyer; Gal Richter-Levin; Avital Avi; Tsoory Michael; Michael Gruss; Jörg Bock; Carina Helmeke; Katharina Braun
Journal:  Dev Psychobiol       Date:  2006-11       Impact factor: 3.038

3.  Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort.

Authors:  Sarah Canetta; Andre Sourander; Heljä-Marja Surcel; Susanna Hinkka-Yli-Salomäki; Jaana Leiviskä; Christoph Kellendonk; Ian W McKeague; Alan S Brown
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

Review 4.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

Review 5.  The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions.

Authors:  H Chang; X Xiao; M Li
Journal:  Mol Psychiatry       Date:  2017-03-14       Impact factor: 15.992

6.  Childhood Socioeconomic Status and Late-Adulthood Mental Health: Results From the Survey on Health, Ageing and Retirement in Europe.

Authors:  Viola Angelini; Daniel D H Howdon; Jochen O Mierau
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2019-01-01       Impact factor: 4.077

Review 7.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

8.  AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.

Authors:  Dawn L Thiselton; Vladimir I Vladimirov; Po-Hsiu Kuo; Joseph McClay; Brandon Wormley; Ayman Fanous; Francis A O'Neill; Dermot Walsh; Edwin J C G Van den Oord; Kenneth S Kendler; Brien P Riley
Journal:  Biol Psychiatry       Date:  2007-09-06       Impact factor: 13.382

9.  Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample.

Authors:  B Riley; D Thiselton; B S Maher; T Bigdeli; B Wormley; G O McMichael; A H Fanous; V Vladimirov; F A O'Neill; D Walsh; K S Kendler
Journal:  Mol Psychiatry       Date:  2009-10-20       Impact factor: 15.992

10.  Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state.

Authors:  Frauke Schultze-Lutter; Stephan Ruhrmann; Julia Berning; Wolfgang Maier; Joachim Klosterkötter
Journal:  Schizophr Bull       Date:  2008-06-25       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.